[Dystonia in cerebral palsy; what are the treatment options?]

Area of Science:

• Neurology
• Pediatrics
• Rehabilitation Medicine

Background:

• Cerebral palsy (CP) is the leading cause of childhood motor disability, primarily affecting children with spasticity.
• Dystonia, characterized by fluctuating hypertonia and involuntary movements, affects an estimated 15% of children with CP, often presenting as dyskinetic CP.
• Dystonia in CP is frequently underdiagnosed despite its significant impact on motor function, caregiving, and patient comfort.

Purpose of the Study:

• To highlight the underdiagnosis of dystonia in children with cerebral palsy.
• To present three case studies of children with dystonia in CP.
• To review current pharmacological and surgical treatment options for dystonia in CP.

Main Methods:

• Review of three clinical cases of children diagnosed with dystonia and cerebral palsy.
• Comprehensive literature review of pharmacological interventions for dystonia in CP.
• Analysis of surgical treatment modalities, including intrathecal baclofen pumps and deep brain stimulation.

Main Results:

• Dystonia, often co-occurring with spasticity, presents unique challenges in children with CP.
• Specific pharmacological treatments can manage dystonia symptoms.
• Surgical interventions like intrathecal baclofen pumps and deep brain stimulation offer advanced therapeutic options.

Conclusions:

• Early recognition and diagnosis of dystonia in children with CP are essential for effective management.
• A multimodal treatment approach, combining pharmacological and surgical strategies, can significantly improve outcomes for children with dystonia in CP.
• Further research and clinical awareness are needed to address the underdiagnosis and optimize treatment for dystonia in pediatric cerebral palsy.